PERSPECTA

News from every angle

Back to headlines

BioNTech Faces Economic Challenges After COVID Vaccine Success

BioNTech, the company behind a major COVID-19 vaccine, is reportedly facing an 'end of an era' as it navigates economic challenges, cuts, and closures after its pandemic-era billions. The company is now placing a significant bet on its cancer research.

14 May, 18:21 — 14 May, 18:21
PostShare